Renal Cancer - Results from #2620

Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms. July 28, 2020

Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort. July 28, 2020

Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma. July 27, 2020

Decreased mitochondrial DNA content drives OXPHOS dysregulation in chromophobe renal cell carcinoma. July 27, 2020

A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma. July 27, 2020

Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma. July 24, 2020

Anomalous retro-psoas iliac artery in a patient with right renal cancer: A case report. July 24, 2020

Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma. July 23, 2020

Management of Residual or Recurrent Disease Following Thermal Ablation of Renal Cortical Tumors. July 23, 2020

Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis. July 23, 2020

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial. July 23, 2020

Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience. July 22, 2020

Molecular Protein and Expression Profile in the Primary Tumors of Clear Cell Renal Carcinoma and Metastases. July 22, 2020

Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma. July 21, 2020

Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis. July 21, 2020

Chronic Kidney Disease After Partial Nephrectomy in Patients With Preoperative Inconspicuous Renal Function - Curiosity or Relevant Issue? July 20, 2020

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial. July 20, 2020

Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression. July 17, 2020

Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report. July 17, 2020

Comprehensive analysis of copy number variance and sensitivity to common targeted therapy in clear cell renal cell carcinoma: In silico analysis with in vitro validation. July 17, 2020

Page 132 of 456